New Album Available from March 6
Finally, the new album, ‘The Boy at the Window’ has a release date of March 6th 2013.
Samples can be listened to on the Music page. See his website for more info: http://www.michaelcunninghamjnr.com/
and like him on facebook: www.facebook.com/michaelcunninghamjnr Continue reading Check out new Irish recording artist Michael Cunningham, Jr.
Graz, Austria and London, UK- 20th February 2013: ProtAffin AG, a biotechnology company developing a novel class of next-generation biopharmaceuticals for inflammation, respiratory disease and oncology, today announced that a collaboration with a leading European centre for the Continue reading Promising pre-clinical data in Cystic Fibrosis for ProtAffin AG’s PA401 to be presented at ATS, Philadelphia, 17-22 May 2013
BEF CF Ambassador, Jerry Cahill, created the You Cannot Fail program to challenge people to discover their own heroism, embrace the ups and downs of their life’s journey, make a difference by sharing that journey with others, and celebrate the stories that make them unique.
As a component of that program, BEF established the Jerry Cahill You Cannot Fail scholarship in 2012 to honor exceptional student-athletes with cystic fibrosis who, like Jerry, don’t let the disease get in their way of living lives filled with purpose, passion, optimism and courage. These Continue reading You Cannot Fail Scholarship Application Deadline: April 18, 2013
February 6th is a big day for the Power of Two!
Ana and Isa will appear on the “Multiple Madness” episode of Katie Couirc’s hit ABC afternoon talk show. Click link below to check local listings for channel and time.
University of Cambridge researchers have discovered how an antibiotic-resistant superbug exploits oxygen-limited conditions in the lungs of patients with severe respiratory disease to thrive.
It is hoped the discovery could lead to new ways to target the Pseudomonas aeruginosabacterium, Continue reading Discovery Of ‘Switch’ That Turns On Aggressive Infection In Superbug Offers Potential New Target For Treatment
Many manufacturers of medications used by CF patients offer patient assistance programs to assist individuals with insufficient or no insurance coverage to obtain medications. Programs vary in their offerings from sampling products, providing nutritional supplements, and co-pay assistance.
Digestive Enzymes Continue reading Saving Money with Patient Assistance Programs
KaloBios Pharmaceuticals, Inc. today announced that dosing has begun in a randomized, double-blind, placebo-controlled Phase 2 clinical trial of KB001-A, the company’s anti-PcrV Humaneered®, PEGylated monoclonal antibody fragment. The study will investigate the safety and efficacy of intravenously administered KB001-A as a treatment for chronic Pseudomonas aeruginosa (Pa) infection in cystic fibrosis patients. Continue reading KaloBios Initiates Phase 2 Study with KB001-A Humaneered® Monoclonal Antibody in Cystic Fibrosis Patients
In the following episode of CF Wind Sprints, Jerry Cahill introduces the question of how to use a feeding tube. Although Jerry has never used a feeding tube, his friend Gunnar Esiason has, and is able to give a short overview of its use.
People with cystic fibrosis (CF) will be able to access the latest research findings about their condition, volunteer for clinical trials and influence the direction of future scientific studies through a new website being launched later this week.
CFUnite.org is the brainchild of academics at The University of Nottingham who wanted to find a way of bringing patients together to discuss scientific and medical breakthroughs without risking Continue reading New website to unite cystic fibrosis patients and researchers